IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

VITIELLO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.420
EU - Europa 1.048
AS - Asia 912
SA - Sud America 106
AF - Africa 22
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.513
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.356
GB - Regno Unito 289
CN - Cina 260
SG - Singapore 244
IT - Italia 224
DE - Germania 163
BD - Bangladesh 115
SE - Svezia 90
BR - Brasile 78
HK - Hong Kong 62
VN - Vietnam 62
RU - Federazione Russa 59
CA - Canada 52
FR - Francia 52
IN - India 46
NL - Olanda 36
FI - Finlandia 33
TR - Turchia 29
UA - Ucraina 28
KR - Corea 24
ID - Indonesia 23
IE - Irlanda 23
BE - Belgio 20
JP - Giappone 18
EU - Europa 17
CO - Colombia 10
CI - Costa d'Avorio 8
MX - Messico 7
AR - Argentina 6
GR - Grecia 6
AT - Austria 5
AE - Emirati Arabi Uniti 4
VE - Venezuela 4
ZA - Sudafrica 4
AU - Australia 3
CL - Cile 3
EC - Ecuador 3
ES - Italia 3
IQ - Iraq 3
MA - Marocco 3
PK - Pakistan 3
PL - Polonia 3
RO - Romania 3
SM - San Marino 3
BG - Bulgaria 2
CH - Svizzera 2
EE - Estonia 2
ET - Etiopia 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
PH - Filippine 2
SA - Arabia Saudita 2
UY - Uruguay 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ER - Eritrea 1
GA - Gabon 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
MW - Malawi 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
TW - Taiwan 1
Totale 3.529
Salva come PNG Salva come JPEG
Città #
Southend 249
Ashburn 142
Singapore 142
Chandler 125
Fairfield 81
Ann Arbor 60
Beijing 59
San Jose 57
Milan 56
Hong Kong 52
Wilmington 52
Santa Clara 50
Seattle 50
Los Angeles 46
Woodbridge 45
Council Bluffs 41
Houston 41
Princeton 40
Cambridge 36
Mountain View 27
Boise 24
Dallas 24
Dearborn 24
Dublin 23
New York 23
Buffalo 22
Helsinki 21
Toronto 21
Brussels 20
Boardman 19
Montreal 19
Redmond 18
Ho Chi Minh City 17
Jakarta 17
Kiez 15
Nanjing 15
Rome 14
Somerville 14
São Paulo 14
Margão 13
Phoenix 13
Bengaluru 12
Frankfurt am Main 12
Lauterbourg 12
Tokyo 12
Cangzhou 11
Seoul 11
Des Moines 10
Hanoi 10
Andover 9
Columbus 9
Florence 9
Guangzhou 9
Sakarya 9
Shenzhen 9
The Dalles 9
Bogotá 8
Dong Ket 8
Eitensheim 8
Falls Church 8
Munich 8
Naples 8
Hefei 7
Moscow 7
Nürnberg 7
Padova 7
Turin 7
Athens 6
Bari 6
Hamburg 6
Jacksonville 6
Redwood City 6
Shanghai 6
Abidjan 5
Da Nang 5
Fremont 5
Hangzhou 5
Odernheim 5
Silver Spring 5
Atlanta 4
Changsha 4
Chennai 4
Chicago 4
Genoa 4
Grafing 4
Hebei 4
Jinan 4
Nuremberg 4
Shenyang 4
Berlin 3
Budenheim 3
Cagliari 3
Catanzaro 3
Cattolica 3
Evanston 3
Falciano 3
Kiel 3
Kwai Chung 3
Lanzhou 3
Montréal 3
Totale 2.216
Salva come PNG Salva come JPEG
Nome #
Maraviroc as Intensification Strategy in HIV-1 Positive Patients with Deficient Immunological Response: an Italian Randomized Clinical Trial 382
Prevalence of mutations and determinants of genotypic resistance to etravirine (TMC125) in a large Italian resistance database (ARCA) 354
Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir 348
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens 341
Does GSS Still Maintain Relevance on HAART Outcome After the Introduction of Newest Active Antiretroviral Drugs? 48 Weeks Results 321
Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART 302
Efficacy of Maraviroc (MVC) as intensification strategy in immunological non-responder (INR) HIV-1-infected patients treated with HAART 253
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation 247
Maraviroc : un inibitore del co-recettore CCR5 con un unico profilo di efficacia e tollerabilita’ in diversi scenari clinici dell'infezione da HIV-1 231
Severe raltegravir-associated rhabdomyolysis: a case report and review of the literature 194
Determinants of virological response to raltegravir (RAL)-containing regimens and prevalence of RAL-resistance associated mutations at failure in ARCA 189
Levofloxacin-induced seizures in a patient without predisposing risk factors : the impact of pharmacogenetics 175
Factors associated with virological success with raltegravir-containing regimens and prevalence of raltegravir-resistance-associated mutations at failure in the ARCA database 174
Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides 142
Totale 3.653
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.515
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022261 31 14 11 8 13 20 21 18 30 29 17 49
2022/2023312 51 50 37 32 24 49 8 15 30 0 14 2
2023/2024158 3 12 4 17 25 13 4 18 1 14 9 38
2024/2025412 7 27 5 52 38 24 11 43 36 41 33 95
2025/20261.011 91 59 58 65 99 64 113 33 87 62 176 104
2026/202763 63 0 0 0 0 0 0 0 0 0 0 0
Totale 3.653